The rising interest in effective weight management has spurred considerable exploration into groundbreaking treatments. Recently , Retatrutide, a dual -action hormone and glucagon-like peptide-1 (GLP-1) receptor agonist , has demonstrated promising results in medical trials, implying potential for s